CN Patent

CN104478879B — 一种作为二肽基肽酶-4抑制剂的化合物

Assigned to ZHEJIANG YONGTAI TECHNOLOGY Co Ltd · Expires 2016-03-02 · 10y expired

What this patent protects

本发明涉及一种作为二肽基肽酶-4(DPP-IV)抑制剂的化合物，可用于治疗可因抑制DPP-IV活性而受益的所有症状或病症，例如I型和II型糖尿病、糖尿病并发症及其它相关疾病。

USPTO Abstract

本发明涉及一种作为二肽基肽酶-4(DPP-IV)抑制剂的化合物，可用于治疗可因抑制DPP-IV活性而受益的所有症状或病症，例如I型和II型糖尿病、糖尿病并发症及其它相关疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN104478879B
Jurisdiction
CN
Classification
—
Expires
2016-03-02
Drug substance claim
No
Drug product claim
No
Assignee
ZHEJIANG YONGTAI TECHNOLOGY Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.